Suppr超能文献

自然资源治疗子宫内膜异位症的潜力:当前进展与未来展望。

Therapeutic Potential of Natural Resources Against Endometriosis: Current Advances and Future Perspectives.

机构信息

Sichuan Provincial Center for Gynaecology and Breast Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, People's Republic of China.

Department of Gynaecology and Obstetrics, Leshan People's Hospital, Leshan, 614003, People's Republic of China.

出版信息

Drug Des Devel Ther. 2024 Aug 21;18:3667-3696. doi: 10.2147/DDDT.S464910. eCollection 2024.

Abstract

Endometriosis (EMS) is defined as the appearance, growth, infiltration, and repeated bleeding of endometrioid tissue (glands and stroma) outside the uterus cavity, which can form nodules and masses. Endometriosis is a chronic inflammatory estrogen-dependent disease and occurs in women of reproductive age. This disorder may significantly affect the quality of life of patients. The pathogenic processes involved in the development and maintenance of endometriosis remain unclear. Current treatment options for endometriosis mainly include drug therapy and surgery. Drug therapy mainly ties to the use of non-steroidal anti-inflammatory drugs (NSAIDs) and hormonal drugs. However, these drugs may produce adverse effects when used for long-term treatment of endometriosis, such as nausea, vomiting gastrointestinal reactions, abnormal liver and kidney function, gastric ulcers, and thrombosis. Although endometriosis lesions can be surgically removed, the disease has a high recurrence rate after surgical resection, with a recurrence rate of 21.5% within 2 years and 40% to 50% within 5 years. Thus, there is an urgent need to develop alternative or additional therapies for the treatment of endometriosis. In this review, we give a systematic summary of therapeutic multiple component prescriptions (including traditional Chinese medicine and so on), bioactive crude extracts of plants/herbs and purified compounds and their newly found mechanisms reported in literature in recent years against endometriosis.

摘要

子宫内膜异位症(EMS)是指子宫内膜样组织(腺体和基质)在子宫腔外的出现、生长、浸润和反复出血,可形成结节和肿块。子宫内膜异位症是一种慢性炎症性雌激素依赖性疾病,发生在育龄妇女中。这种疾病可能会显著影响患者的生活质量。子宫内膜异位症的发病机制尚不清楚。目前子宫内膜异位症的治疗选择主要包括药物治疗和手术治疗。药物治疗主要涉及非甾体抗炎药(NSAIDs)和激素药物的使用。然而,这些药物在长期治疗子宫内膜异位症时可能会产生不良反应,如恶心、呕吐、胃肠道反应、肝肾功能异常、胃溃疡和血栓形成。虽然可以通过手术切除子宫内膜异位症病变,但手术后疾病的复发率很高,术后 2 年内复发率为 21.5%,术后 5 年内复发率为 40%至 50%。因此,迫切需要开发治疗子宫内膜异位症的替代或附加疗法。在这篇综述中,我们系统地总结了近年来文献报道的针对子宫内膜异位症的多种成分处方(包括中药等)、植物/草药的生物活性粗提取物和纯化化合物及其新发现的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a5/11345706/33a9b3a29821/DDDT-18-3667-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验